Literature DB >> 15564701

Association between small dense low-density lipoprotein and postprandial accumulation of triglyceride-rich remnant-like particles in normotriglyceridemic patients with myocardial infarction.

Fumiyoshi Tsunoda1, Shinji Koba, Tsutomu Hirano, Yoshihisa Ban, Yoshitaka Iso, Hiroshi Suzuki, Eiichi Geshi, Takashi Katagiri.   

Abstract

BACKGROUND: Although the small dense low-density lipoprotein (sd-LDL) is associated with hypertriglyceridemia, more than 60% of myocardial infarction (MI) patients are normotriglyceridemic in the fasting state. This study was aimed to investigate the relationship between the low-density lipoprotein (LDL) phenotype and postprandial hyperlipemia (PPL) in MI patients. METHODS AND
RESULTS: Oral fat tolerance tests were performed in 71 patients with acute MI and fasting triglyceride concentrations below 200 mg/dl. Postprandial changes in the LDL particle diameter (LDL-PD) and lipids over a 6-h period after a meal were compared among 4 groups of patients classified according to fasting triglyceride levels (A, B as <150, and C, D as > or =150) and postprandial triglyceride levels (A, C as <230 and B, D as > or =230). Although fasting concentrations of triglyceride and remnant-like particle (RLP)-triglyceride were significantly higher in group C than in group B, the areas under the curves of the RLPs were significantly higher in group B. The triglyceride-to-cholesterol ratio in the RLPs was significantly higher in the PPL group than in the nonPPL group postprandially. The prevalence of sd-LDL (LDL-PD < or =25.5 nm) was significantly higher in group D but similar between groups B and C (23%, 42%, 50% and 83% in groups A, B, C and D, respectively).
CONCLUSION: These results suggest that postprandial accumulation of triglyceride-rich lipoproteins is strongly associated with sd-LDL in MI patients without hypertriglyceridemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564701     DOI: 10.1253/circj.68.1165

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS.

Authors:  Erkan Cure; Abdullah Icli; Ali Ugur Uslu; Davut Sakiz; Medine Cumhur Cure; Rabia Aydogan Baykara; Fatma Yavuz; Sevket Arslan; Adem Kucuk
Journal:  Clin Rheumatol       Date:  2018-02-12       Impact factor: 2.980

2.  Mesenchymal Stem Cell-Derived Extracellular Vesicle-Shuttled microRNA-302d-3p Represses Inflammation and Cardiac Remodeling Following Acute Myocardial Infarction.

Authors:  Yuanyuan Liu; Rongchun Guan; Jizhou Yan; Yueping Zhu; Shiming Sun; Yan Qu
Journal:  J Cardiovasc Transl Res       Date:  2022-02-22       Impact factor: 4.132

3.  Serum small dense low-density lipoprotein concentrations are elevated in patients with significant coronary artery stenosis and are related to features of the metabolic syndrome.

Authors:  Shima Yazdandoust; Seyyed Mohammad Reza Parizadeh; Mohsen Moohebati; Parichehreh Yaghmaei; Amir Ali Rahsepar; Shima Tavallaie; Mohammad Soukhtanloo; Roshanak Khojasteh; Roghayeh Paydar; Afsoon Fazlinezhad; Homa Falsoleiman; Mashalla Dehghani; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  Lipids       Date:  2012-08-18       Impact factor: 1.880

4.  Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.

Authors:  Toshiyuki Hayashi; Tomoyasu Fukui; Noriko Nakanishi; Saki Yamamoto; Masako Tomoyasu; Anna Osamura; Makoto Ohara; Takeshi Yamamoto; Yasuki Ito; Tsutomu Hirano
Journal:  Cardiovasc Diabetol       Date:  2017-01-13       Impact factor: 9.951

5.  Fasting remnant lipoproteins can predict postprandial hyperlipidemia.

Authors:  Tomoki Nagata; Daisuke Sugiyama; Takako Kise; Satomi Tsuji; Hideo Ohira; Itsuko Sato; Mari Yamamoto; Hitomi Kohsaka; Seiji Kawano; Shizuya Yamashita; Yuichi Ishikawa; Yoshio Fujioka
Journal:  Lipids Health Dis       Date:  2012-10-31       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.